developtreatment

22 results found.

Top Stocks matching your search for "develop treatment"

Click Learn More to know about Stock Advisor's top picks. We've 3x'd the S&P 500 over the last 20 years.

02/0902/1402/1702/2302/2803/0303/0803/1303/1603/21
SLS

SELLAS Life Sciences Group Inc

-63.99%

$3.61 - $1.30

Feb 7th 2023 - Mar 21st 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Mar, 20, 2023

These patients experienced about 35% longer surviv... See more

Mar, 20, 2023

* Best Available Therapy offers 6-8 months of Over... See more

02/0902/1402/1702/2302/2803/0303/0803/1303/1603/21
PPBT

Purple Biotech Ltd - ADR

10.58%

$1.89 - $2.09

Feb 7th 2023 - Mar 21st 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Mar, 15, 2023

$PPBT happy that Dr. Curran is on our MD Anderson ... See more

Jan, 3, 2023

$PPBT cure for cancer 5% up….

02/0602/0802/1002/1402/1602/2102/2302/2703/0103/0303/0703/10
SRNE

Sorrento Therapeutics Inc

-69.12%

$1.02 - $0.32

Feb 2nd 2023 - Mar 10th 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Feb, 22, 2023

We will continue our important work of developing ... See more

Jan, 22, 2023

With the ease of rapid, large scale Good Manufactu... See more

SLS

SELLAS Life Sciences Group Inc

-63.99%

$3.61 - $1.30

Feb 7th 2023 - Mar 21st 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Mar, 20, 2023

These patients experienced about 35% longer survival than has been reported for other second-line therapies.

Mar, 20, 2023

* Best Available Therapy offers 6-8 months of Overall Survival * All pooled Regal patients, BAT and Gps combined, is 16 months.

Mar, 17, 2023

* Best Available Therapy offers 6-8 months of Overall Survival * All pooled Regal patients, BAT and Gps combined, is 16 months.

Mar, 17, 2023

* Best Available Therapy offers 6-8 months of Overall Survival * All pooled Regal patients, BAT and Gps combined, is 16 months.

Mar, 13, 2023

Good cancer stock from what I hear in 2028.

Feb, 6, 2023

$MRK Ovarian cancer data final P2 results are better than any other drugs by a mile.

Feb, 3, 2023

They address a broad range of cancer indications.

Feb, 3, 2023

$SLS Gps arm 22 months of median Overall Survival Best Available Therapy 8.

Feb, 1, 2023

$SLS In addition to GPs FDA approval for AML secondary Remission patients - Gps + Keytruda/Checkpoint Inhibition is also best in class for Ovarian cancer patients.

Jan, 24, 2023

The nation’s best means the O'Neal Comprehensive Center in Alabama have access to the latest therapies, cutting-edge clinical trials and the expertise needed to treat their cancer.

PPBT

Purple Biotech Ltd - ADR

10.58%

$1.89 - $2.09

Feb 7th 2023 - Mar 21st 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Mar, 15, 2023

$PPBT happy that Dr. Curran is on our MD Anderson team… glioblastoma 😉

Jan, 3, 2023

$PPBT cure for cancer 5% up….

Dec, 30, 2022

but I find it good therapy and it is too early to start drinking 😂

Dec, 20, 2022

This thing is showing huge promise with (blood) cancer.

Dec, 14, 2022

The data (if that’s even real at this point) is incredible - find me a preliminary phase 2 cancer drug that caused complete remission in multiple patients at THE LOWEST DOSE!!

Dec, 13, 2022

MRNA showing promise in their cancer vaccine.

Dec, 6, 2022

It got fast fda tracked with their trial ongoing with Roche as the partner for pancreatic cancer 🤷🏻‍♂️👀

Dec, 1, 2022

It’s pharmakinetics are simply the most promising on the market for hard-to-treat cancers.

Nov, 30, 2022

$PPBT Lot of preclinical research with 157 in many countries, targeting different cancers and showing promising results.

Sep, 29, 2022

Also One of the best cancer center.

SRNE

Sorrento Therapeutics Inc

-69.12%

$1.02 - $0.32

Feb 2nd 2023 - Mar 10th 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Feb, 22, 2023

We will continue our important work of developing new and innovative therapies for patients struggling with cancer, intractable pain, infectious disease, and more.

Jan, 22, 2023

With the ease of rapid, large scale Good Manufacturing Practice-grade mRNA production, mRNA is ideally poised not only for off-the shelf cancer vaccines

Jan, 18, 2023

$SRNE your money is well spent , your helping research cancer & everyone here has lost a loved one https://www.cancer.org/treatment/treatments-and-side-effects/treatment-types/immunotherapy.html

Dec, 10, 2022

It‘s extremely distracting because this woman might have the most perfect breast I have ever seen.

Nov, 9, 2022

$SRNE $THER Ther good buy with $1 target with cancer assay news https://www.prnewswire.com/news-releases/theralink-technologies-appoints-dr-mattia-cremona-as-its-director-of-its-biopharma-laboratory-301669138.html